Empress Therapeutics
Biotechnology ResearchView the employees at
Empress Therapeutics-
Murray McKinnon, Ph.D. Chief Scientific Officer, Empress Therapeutics
-
Washington Crossing, Pennsylvania, United States
-
Top 5%
Kevin Kreutter VP, Drug Discovery at Empress Therapeutics-
Greater Boston
-
Rising Star
Alexander Triassi Scientist II, Synthetic Biology at Empress Therapeutics-
Cambridge, Massachusetts, United States
-
Top 10%
Aarti Rohira Senior Scientist at Empress Therapeutics-
Cambridge, Massachusetts, United States
-
Rising Star
Alexander Triassi Scientist II, Synthetic Biology at Empress Therapeutics-
Cambridge, Massachusetts, United States
-
Top 10%
Overview
Founded by Flagship Pioneering in 2020, Empress Therapeutics generates good medicines, fast, by starting with chemistry inside the human body. The Empress Chemilogics(TM) platform uses novel insights that connect the lines of code in DNA with drug-like chemistry made in the human body to create first- or best-in-class oral medicines for a broad range of diseases quickly, predictably, and cost-effectively.
-